Wrong medicine kills US Dollar

The doctors were called in, the patient was very ill but still not life threatening sick. They unanimous diagnosed too much debt as cause of the illness and described restructuring instead of reviving his...

MedImmune`s motavizumab reduced Rsv Hospitalizations

Medimmune's Motavizumab Reduced Rsv Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study (Full text of a statement. Contact details follow below.) Gaithersburg, Md. (ANTARA News/PRNewswire-AsiaNet) -...

closeSign in to NowPublic

is reporting from